The MDCRN meeting was a success! Thanks to all for working towards treatments for myotonic dystrophy, Charcot Marie tooth disease, facioscapulohumeral muscular dystrophy, and limb girdle muscular dystrophy!
Nicholas Johnson retweeted
We're hiring! We are excited to be in our new home @VCU in Richmond, VA and are actively recruiting lab members at all levels! If you're interested in basic or translational science in dystrophic muscle 💪 or heart ❤️, contact us!
Nicholas Johnson retweeted
Learn more about one of MDF's 2024 Research Fellows, Ms. Alexandra Marrero Quinones! Her long-term goal is to identify genetic modifiers of disease severity in #myotonicDystrophy. Learn more at: myotonic.org/research-fellow…
Deletion of miR-146a enhances therapeutic protein restoration in model of dystrophin exon skipping ncbi.nlm.nih.gov/pmc/article…
Deletion of miR-146a enhances therapeutic protein restoration in model of dystrophin exon skipping biorxiv.org/content/10.1101/…
The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1 biorxiv.org/content/10.1101/…
Nicholas Johnson retweeted
CHLA Neuroimmunology expert @Drjonsantoro shares breakthrough discovery in Down Syndrome Regression Disorder with @washingtonpost. chla.org/blog/hospital-news/…
Nicholas Johnson retweeted
Myotonic dystrophy is an autosomal dominant form of muscular dystrophy characterized by progressive muscle weakness and wasting.
JAMA Insights discusses the signs and symptoms, diagnosis, and treatment of myotonic dystrophy type 1.
ja.ma/49Okvav
Nicholas Johnson retweeted
You’re never too young to be an advocate for a better healthcare system! #AANadvocacy #NOH24 @AANmember @nickjohnson30 @WNGtweets @thgr_neurores @thgr_vasc_neuro
Nicholas Johnson retweeted
For more information: curecalpain3.org/trial-readi…
Great MDCRN meeting to advance treatments for myotonic dystrophy, limb girdle muscular dystrophy and facioscapulohumeral muscular dystrophy! @childrensatvcu @VCUNeuro @MyoStrong @CureCalpain3 @FSHDSociety
Moving research forward in myotonic dystrophy at CIMR! #internationalmyotonicdystrophyday #myotonicstrong @VCUNeuro
Nicholas Johnson retweeted
If you or a family member have myotonic dystrophy, the #1 thing you can do to help researchers develop an effective treatment is to enroll in the END-DM1 natural history study. Details here: clinicaltrials.gov/ct2/show/…
Cynthia Gagnon and Guillaume Bassez presenting on the classification of myotonic dystrophy at our dmcrn meeting
Andy Berglund @TheRNAInstitute presenting to the dmcrn on natural products that rescue splicing.
























